← the graveyard
Sumatriptan Nasal Spray
no longer on the FDA list · Neurology · Removed 2026-09-09
This drug was removed from the FDA's shortage list on 2026-09-09. The FDA does not say why a listing is removed. What follows is the last record we saw, from the 2026-09-08 snapshot, when its status was being discontinued. It is an archive, not current information, and it is not counted in any figure elsewhere on this site.
- Manufacturers listed (last seen)
- Prasco Laboratories
- Machine-readable
- JSON for this drug
Presentations as last listed (2)
| Presentation | Company | Availability | Updated |
|---|---|---|---|
| Imitrex, Nasal Spray, 20 mg/100 uL (NDC 66993-082-69) | Prasco Laboratories | unknown | 09/08/2025 |
| Imitrex, Nasal Spray, 5 mg/100 uL (NDC 66993-081-69) | Prasco Laboratories | unknown | 09/08/2025 |
History
Daily tracking of this drug began 2026-08-25 (the first day of the archive).
- 2026-09-09 — Sumatriptan Nasal Spray was removed from the FDA list (was being discontinued)
Each daily snapshot is compared with the one before it; status changes, availability-wording revisions, and arrivals or removals are listed here. A change the FDA makes and reverses between two snapshots is not seen. Every daily record is kept in the public repository.
Not medical advice. ShortSupply republishes the FDA's drug-shortage data with history added. Talk to your pharmacist or prescriber about your situation — never change medication based on this site.